The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of tesetaxel, an oral taxane, given as a single-agent in patients (Pts) with HER2-, hormone receptor + (HR+) locally advanced or metastatic breast cancer (MBC) in a phase 2 study.
 
Andrew David Seidman
Honoraria - Eisai; Genentech; Genomic Health; Nektar; Novartis; Odonate Therapeutics; Pfizer
Consulting or Advisory Role - Eisai; Genentech; Merrimack; Nektar; Odonate Therapeutics; Pfizer
Speakers' Bureau - Eisai; Genentech; Genomic Health; Novartis; Pfizer
Research Funding - Bayer (Inst); Nektar (Inst); Novartis (Inst); Odonate Therapeutics (Inst)
 
Lee Steven Schwartzberg
Honoraria - Amgen; NanoString Technologies; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Life Sciences; Genomic Health; Helsinn Therapeutics; Pfizer; Spectrum Pharmaceuticals; Tesaro
 
Vinay K. Gudena
Consulting or Advisory Role - Cardinal Health; Genomic Health; Pfizer
 
Peter Rubin
Speakers' Bureau - Celgene; Genomic Health
Travel, Accommodations, Expenses - Celgene
 
Stew Kroll
Employment - La Jolla Pharma; Odonate Therapeutics; Sentier Therapeutics; Threshold Pharmaceuticals
Stock and Other Ownership Interests - La Jolla Pharma; Odonate Therapeutics; Sentier Therapeutics; Threshold Pharmaceuticals
 
Joseph P. O'Connell
Employment - inVentiv Health; Odonate Therapeutics
Leadership - Odonate Therapeutics
Stock and Other Ownership Interests - inVentiv Health; Odonate Therapeutics
Travel, Accommodations, Expenses - inVentiv Health; Odonate Therapeutics
 
Kevin Tang
Employment - Odonate Therapeutics
Leadership - HERON; La Jolla Pharma; Odonate Therapeutics; Sentier Therapeutics
Stock and Other Ownership Interests - BioCryst; Biomarin; BioReference Laboratories; Celldex; Cyclacel; HERON; Horizon Pharma; Ignyta; Infinity Pharmaceuticals; La Jolla Pharma; Lipocine; Merrimack; Mirati Therapeutics; Nektar; OncoGenex; OPKO Health; RxAnte; Salix; Sarepta Therapeutics; Sentier Therapeutics
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Arno Therapeutics; AstraZeneca; Celgene; Eisai; Genentech/Roche; Lilly; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Arno Therapeutics; AstraZeneca; Celgene; Eisai; Genentech/Roche; Lilly; Nektar; Novartis; Pfizer
Travel, Accommodations, Expenses - Abbvie; Celgene; Lilly; Nektar; Novartis; Pfizer